Optimal management of digital ulcers in systemic sclerosis


Raynaud's phenomenon and digital ulcerations are two common clinical features seen in patients with systemic sclerosis. They are painful and lead to significant morbidity and altered hand function within this patient population. While currently there are no US Food and Drug Administration (FDA)-approved medications for the treatment of digital ulcerations… (More)
DOI: 10.2147/TCRM.S82561


1 Figure or Table

Cite this paper

@inproceedings{Abraham2015OptimalMO, title={Optimal management of digital ulcers in systemic sclerosis}, author={Shawn Abraham and Virginia Steen}, booktitle={Therapeutics and clinical risk management}, year={2015} }